Maven Semantic: Atrial Fibrillation Research Database

Search Over 20,000 People and Over 1,000 Atrial Fibrillation Research Organisations

DUBLIN--(BUSINESS WIRE)-- Maven Semantic (http://www.mavensemantic.com) announces updates to their Atrial Fibrillation research database.

The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

The database currently tags 20,000 individuals working in Atrial Fibrillation. http://bit.ly/awjYLY .

Top 10 Countries for Atrial Fibrillation Research (ranked by number of senior Atrial Fibrillation researchers)

. United States Of America (6,144)

. Japan (1,444)

. Germany (1,217)

. Italy (1,115)

. United Kingdom (1,103)

. Canada (700)

. France (648)

. China (539)

. The Netherlands (487)

. Spain (454)

Leading organisations in Atrial Fibrillation research include:

. Mayo Clinic

. Harvard Medical School

. University of California

. Duke University Medical Center

. Cleveland Clinic Foundation

. Massachusetts General Hospital

. Washington University School of Medicine

. Brigham and Women's Hospital

. National Cardiovascular Center

. The Cleveland Clinic Foundation

. University of Toronto

. Institute of Cardiology

. University of Michigan

. Montreal Heart Institute

. Queen Mary Hospital

. McMaster University

. Cedars-Sinai Medical Center

. Aarhus University Hospital

. Johns Hopkins University School of Medicine

. University of Groningen

. Nippon Medical School

. Taipei Veterans General Hospital

. University of Birmingham

. St. George's Hospital Medical School

. Beth Israel Deaconess Medical Center

. Royal Melbourne Hospital

. Hartford Hospital

. Cardiovascular Research Institute Maastricht

. Albert Einstein College of Medicine

. National Yang-Ming University

. Nihon University School of Medicine

. Chang Gung Memorial Hospital

The database also includes pharmaceutical companies, biotech companies, CROs, hospitals, government labs and other organisations active in the Atrial Fibrillation research field.

Sample companies in database include:

. Medtronic, Inc

. InControl, Inc

. Aventis Pharma Deutschland GmbH

. Guidant Corporation

. Hamad Medical Corporation

. Städtisches Klinikum München GmbH

. Boston Scientific Corporation

. Kerckhoff-Klinik GmbH

. Oxford Outcomes Ltd

. REGISTRAT Inc

. SymbioTec GmbH

. Bayer HealthCare AG

. Boston Health Economics, Inc

. CV Therapeutics, Inc

. Cardiac Surgical Associates

. Cardiome Pharma Corporation

. Celgene Corporation

. CryoCor Inc

. Epidemiology Enterprises, LLC

. Hamilton Health Sciences Corporation

. Health Care Research Center, Inc

. Italfarmaco SpA

. MED Institute, Inc

. Sanofi-Aventis Deutschland GmbH

. St. Jude Medical, Inc

. The Care Group, LLC

. United BioSource Corporation

. Wyeth Laboratories, Inc

What is Maven:

- Largest database of international medical professionals, with over 6,000,000 people and over 500,000 medical organisations;

- All records are downloadable to excel or in-house database, with email, postal address and phone contacts;

- Profile and segment the entire database using over 47,000 diseases and therapeutic areas

What is Maven used for:

- Building prospect lists for postal, telesales and email campaigns

- Locating key decision makers in companies, hospitals, government labs, university labs, and other healthcare facilities

- Identifying candidates for recruitment to very specific life science positions

About the Maven Semantic Medical Database: The current database holds over 6 million medical professionals, and 500,000 medical organisations.

The Maven Semantic medical database covers pharmaceutical, biotech and medical device companies, clinical research labs, hospitals, medical universities and government research organisations.

Maven is a SaaS subscription-based service. Clients can choose from quarterly or yearly subscriptions, or as pay-as-you-go option to retrieve specific large datasets for in-house use.

Results can be viewed online, or exported to Excel or a CRM system.

The data is now available to international healthcare marketing teams.

About our Technology: Semantic data mining tools have been used to create a database of detailed profiles of life science companies and executives.

The system uses the open web as an underlying database and extracts specific information on people, job titles, biographies, research profiles, contact details (dept., phone, fax, and email), organisation profiles, websites, product/services and much more.

Maven is based on healthcare crawlers/bots, search technology, semantic parsers, clustering, natural language processing (NLP) and artificial intelligence (AI) technology.

"The system uses the context in which a given person appears, using artificial intelligence techniques to find out information not otherwise visible - for example, how important is this person in a specific medical research specialization," says Alejandro Mesas, Semantic Systems Architect. "The big advantage of a focused semantic healthcare database over a generic search engine is that it has built-in taxonomies and a thesaurus to expand and refine the user queries. We then use scoring and ranking to fine tune the relevance of the results for a given therapeutic area. For example, stem cell researchers are given a "page rank", based on where they work, their job title, how many times they have published, where they have published, etc. The relevance can be fine tuned by the user".

For more information visit http://www.mavensemantic.com/



CONTACT:

Maven Semantic
Bryan McManmon
[email protected]
Ph: + 353 1 4100699

KEYWORDS:   United States  Europe  Asia Pacific  North America

INDUSTRY KEYWORDS:   Health  Biotechnology  Cardiology  Hospitals  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.